Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2007 1
2008 6
2009 6
2010 5
2011 7
2012 3
2013 7
2014 5
2015 8
2016 6
2017 4
2018 8
2019 8
2020 8
2021 8
2022 9
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Gross O, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, Zappel H, Hoyer P, Staude H, König S, John U, Gellermann J, Hoppe B, Galiano M, Hoecker B, Ehren R, Lerch C, Kashtan CE, Harden M, Boeckhaus J, Friede T; German Pediatric Nephrology (GPN) Study Group and EARLY PRO-TECT Alport Investigators. Gross O, et al. Kidney Int. 2020 Jun;97(6):1275-1286. doi: 10.1016/j.kint.2019.12.015. Epub 2020 Jan 17. Kidney Int. 2020. PMID: 32299679 Free article. Clinical Trial.
Immunoadsorption in steroid-refractory multiple sclerosis.
Koziolek MJ, Kitze B, Mühlhausen J, Müller GA. Koziolek MJ, et al. Atheroscler Suppl. 2013 Jan;14(1):175-8. doi: 10.1016/j.atherosclerosissup.2012.10.026. Atheroscler Suppl. 2013. PMID: 23357161 Review.
Apheresis in treatment of acute inflammatory demyelinating disorders.
Mühlhausen J, Kitze B, Huppke P, Müller GA, Koziolek MJ. Mühlhausen J, et al. Among authors: koziolek mj. Atheroscler Suppl. 2015 May;18:251-6. doi: 10.1016/j.atherosclerosissup.2015.02.037. Atheroscler Suppl. 2015. PMID: 25936333 Review.
Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials.
von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U. von Haehling S, et al. Among authors: koziolek m. Eur J Heart Fail. 2021 Jan;23(1):92-113. doi: 10.1002/ejhf.1838. Epub 2020 May 11. Eur J Heart Fail. 2021. PMID: 32392403 Free article. Review.
[Blood pressure treatment in the acute stage of stroke].
Koziolek MJ, Lüders S. Koziolek MJ, et al. Dtsch Med Wochenschr. 2015 Oct;140(21):1587-92. doi: 10.1055/s-0041-107338. Epub 2015 Oct 21. Dtsch Med Wochenschr. 2015. PMID: 26488097 Review. German.
Impact of medication adherence on the efficacy of Baroreflex activation therapy.
Schäfer AC, Müller D, Born E, Mühlhaus M, Lüders S, Wallbach M, Koziolek MJ. Schäfer AC, et al. Among authors: koziolek mj. J Clin Hypertens (Greenwich). 2022 Aug;24(8):1051-1058. doi: 10.1111/jch.14540. Epub 2022 Jul 23. J Clin Hypertens (Greenwich). 2022. PMID: 35870124 Free PMC article.
93 results